4 ms·

A billion doses or so have already been manufactured around the world or are very close to. It's also substantially cheaper and as others said, way easier to st

A billion doses or so have already been manufactured around the world or are very close to. It's also substantially cheaper and as others said, way easier to store and transport. It will make a huge difference in the non-rich countries. Leaked prices from the EU: -Oxford/AstraZeneca: €1.78 -Johnson & Johnson: $8.50 -Sanofi/GSK: €7.56 -BioNTech/Pfizer: €12 -CureVac: €10 -Moderna: $18

c1505 6y ago
Where are you getting that information about a billion doses already manufactured? Would be great if true!
- rtx 6y ago
  There is a company called Serum Institute they have been doing production for sometime now. https://www.businesstoday.in/current/corporate/serum-institute-to-double-covishield-vaccine-production-to-100-million-month/story/423301.html https://www.businesstoday.in/current/corporate/serum-institu...
wyldfire 6y ago
Is the price a result of the cost to produce it, or is it price adjusted, reflecting the relative demand? Perhaps there's limited demand for a vaccine if the mixed results undermines confidence. Also, it would be interesting to understand the global pricing. Due to market segmentation, there could be inconsistent local pricing among the manufacturers.
angry_octet 6y ago
This is a bit confused with different currencies being used with implied ordering... USD 0.82 -> €1.00 Oxford/AstraZeneca: €1.78 -Johnson & Johnson: US$8.50 €6.97 -Sanofi/GSK: €7.56 -CureVac: €10 -BioNTech/Pfizer: €12 -Moderna: US$18 €14.76
- kurthr 6y ago
  I'd go one step further and point out that J&J also requires only one shot (assuming they can reach high effectiveness ~90% without significant side effects <100ppm). Not only is there reduced logistical challenge which is easily >$10, but the others are only listed at half the effective price since they have to be given twice 3-4 weeks apart!
  - angry_octet 6y ago
    Although there is significant consideration being given to giving only one dose of Pfizer/Moderna, i.e. a health system operated stage 4 trial. At least I hope they do the effort to make it a proper trial, it might be a shambolic politically driven cluster fuck. (Do you get an 'immunity passport' with only one shot? Which vaccines do countries recognize? The Russian and Chinese ones with NO clinical trial data?)
    - smileysteve 6y ago
      Nobody needs an immunity passport once a location is back below community spread. Once a location has a low local positivity rate, testing and contact tracing are effective again. This should start occurring naturally once essential workers are vaccinated; then any partial lockdown or additional vaccination should destroy community spread.
      - angry_octet 6y ago
        Practically speaking, countries will likely require proof of immunisation for international travel. Maybe not the US, though I wouldn't go there without it. I'd also expect it would become expensive to get travel insurance without immunisation.
ketamine__ 6y ago
Your points don't address my question.

c1505 6y ago

Where are you getting that information about a billion doses already manufactured? Would be great if true!

rtx 6y ago
There is a company called Serum Institute they have been doing production for sometime now. https://www.businesstoday.in/current/corporate/serum-institute-to-double-covishield-vaccine-production-to-100-million-month/story/423301.html https://www.businesstoday.in/current/corporate/serum-institu...

wyldfire 6y ago

Is the price a result of the cost to produce it, or is it price adjusted, reflecting the relative demand? Perhaps there's limited demand for a vaccine if the mixed results undermines confidence. Also, it would be interesting to understand the global pricing. Due to market segmentation, there could be inconsistent local pricing among the manufacturers.

angry_octet 6y ago

This is a bit confused with different currencies being used with implied ordering... USD 0.82 -> €1.00 Oxford/AstraZeneca: €1.78 -Johnson & Johnson: US$8.50 €6.97 -Sanofi/GSK: €7.56 -CureVac: €10 -BioNTech/Pfizer: €12 -Moderna: US$18 €14.76

kurthr 6y ago
I'd go one step further and point out that J&J also requires only one shot (assuming they can reach high effectiveness ~90% without significant side effects <100ppm). Not only is there reduced logistical challenge which is easily >$10, but the others are only listed at half the effective price since they have to be given twice 3-4 weeks apart!
- angry_octet 6y ago
  Although there is significant consideration being given to giving only one dose of Pfizer/Moderna, i.e. a health system operated stage 4 trial. At least I hope they do the effort to make it a proper trial, it might be a shambolic politically driven cluster fuck. (Do you get an 'immunity passport' with only one shot? Which vaccines do countries recognize? The Russian and Chinese ones with NO clinical trial data?)
  - smileysteve 6y ago
    Nobody needs an immunity passport once a location is back below community spread. Once a location has a low local positivity rate, testing and contact tracing are effective again. This should start occurring naturally once essential workers are vaccinated; then any partial lockdown or additional vaccination should destroy community spread.
    - angry_octet 6y ago
      Practically speaking, countries will likely require proof of immunisation for international travel. Maybe not the US, though I wouldn't go there without it. I'd also expect it would become expensive to get travel insurance without immunisation.

ketamine__ 6y ago

Your points don't address my question.